Apple AirPods Pro 3 vs EarCentric EX2

The Apple AirPods Pro 3 is a budget-priced OTC hearing aid released in 2025, earning a B grade with a SoundScore of 3.3/5 in our lab testing. At $250, it sits in the most affordable price tier of OTC devices, though its overall sound performance ranks #49 of 65 in the category. This device delivers standout performance in music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect excellent stability without whistling or squealing during normal use. These strengths make the AirPods Pro 3 particularly appealing for users who prioritize media consumption alongside hearing assistance. However, speech clarity presents a more mixed picture. Speech in quiet scores 2.3/5, falling 0.53 points below the category average. Speech in noise measures 1.8/5, which is above the category average but still low in absolute terms. Own-voice comfort also trails at 1.9/5, sitting 0.61 points below typical OTC performance. The AirPods Pro 3 is best suited for users already invested in the Apple ecosystem who want hearing assistance combined with premium streaming quality. Those prioritizing speech understanding in conversations may want to explore alternatives like the Apple AirPods Pro 2, which scores higher overall at a lower listed price, or the Elehear Beyond at the top of this price range.

The EarCentric EX2 is a budget-priced prescription behind-the-ear hearing aid released in 2021, earning a C grade with a SoundScore of 2.7/5 in HearAdvisor's lab testing. At $218, it ranks #33 of 36 prescription hearing aids tested, placing it in the bottom 11% of its category. In our testing, the EX2 showed a significant split in performance. Feedback handling was excellent at 4.7/5, essentially matching the category average and demonstrating stable operation during movement. However, speech performance was notably limited, with both speech in quiet and speech in noise scoring 1.0/5—well below the category averages of 3.32 and 1.96 respectively. Music streaming scored 0.0/5, falling 2.64 points below the prescription category average of 2.64/5. Own-voice comfort scored 2.3/5, a mixed result that sits 0.45 points below the category average. The device uses a rechargeable battery, which adds convenience for daily use. Notably, tuning did not improve performance in our testing—the Initial and Tuned fit scores were identical at 2.7/5. Budget-conscious shoppers in this price range may want to compare alternatives. The RxEars Rxi scored 4.09/5 at a similar price point, while OTC options like the Audien Hearing Atom offer comparable or better sound performance at lower prices. The EX2 may suit users who prioritize feedback stability and rechargeable convenience over speech clarity, but its limited speech performance is a significant tradeoff.